Coronary vasomotor responses in cyclosporine-treated piglets

Cardiovascular Drugs and Therapy

Volumn 10, Issue 1, 1996, Pages 17-22

  Berkenboom, Guy ^a   Brékine, Dmitri ^a   Unger, Philippe ^a   Gulbis, Béatrice ^a   Fontaine, Jeanine ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Coronary artery; Cyclosporine; EDRF; Piglet

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CALCIUM IONOPHORE; CYCLOSPORIN; CYCLOSPORIN A; INDOMETACIN; KETANSERIN; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY HEMODYNAMICS; HEART GRAFT; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR DISEASE; VASOMOTOR REFLEX;

EID: 0029919256     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051126     Document Type: Article

References (23)

1. Myers BD. Cyclosporine-associated hypertension. Am J Med 1988;85:131-133.
2. Schachter M. Cyclosporine A and hypertension. J Hypertens 1988;5:511-516.
3. Ausch-Schwelk W, Bossaller C, Götze S, Thelen J, Fleck E. Endothelial and vascular smooth muscle function after chronic treatment with cyclosporine A. J Cardiovasc Pharmacol 1993;21:435-440.
4. Berkenboom G, Unger P, Goldman M, Fang ZY, Fontaine J. Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline. J Cardiovasc Pharmacol 1991;18:761-768.
5. Bossaller C, Försterman U, Hertel R, Obricht C, Reschke V, Fleck E. Cyclosporine A inhibits endothelium-dependent vasodilation and vascular prostacyclin production. Eur J Pharmacol 1989;165:165-169.
6. Gallego MJ, Lopez Farré A, Riesco A, et al. Blockade of endothelium-dependent responses in conscious rats by cyclosporine A: Effect of L-arginine. Am J Physiol 1993; 264:H708-H714.
7. O'Neil GS, Chester AH, Kushwaha S, Rose M, Tadjkarimi S, Yacoub MH. Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries. Br Heart J 1991;66-.212-216.
8. Okumara K, Yasue H, Ishizaka H, Ogawa H, Fujii H. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 1992;20:838-844.
9. Kalsner S. Coronary reactivity in human vessels: Some questions and some answers. Fred Proc 1985;44:321-325.
10. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988;63:903-910.
11. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991;83: 652-660.
12. Christie MI, Griffith TM, Lewis MJ. A comparison of basal and agonist-stimulated release of endothelium-derived relaxing factor from different arteries. Br J Pharmacol 1989; 98:397-406.
13. Gräser J, Leisner A, Tiedt N. Absence of role of endothelium in the response of isolated porcine coronary arteries to acetylcholine. Cardiovasc Res 1986;20:299-302.
14. Chan BBK, Kern JA, Flanagan TL, Kron IL, Tribble CG. Effects of in vivo cyclosporine administration on endothelium-dependent responses in isolated vascular rings. Circulation 1991;86(Suppl II):II295-II299.
15. Berkenboom G, Unger P, Fang ZY, Degré S, Fontaine J. Comparison of responses to acetylcholine and serotonin on isolated canine and human coronary arteries. Cardiovasc Res 1989;23:780-787.
16. Toda N, Okamura T. Endothelium-dependent and independent responses to vasoactive substances of isolated human coronary arteries. Am J Physiol 1989;257:H988-H995.
17. Berkenboom G, Brékine D, Unger P, Gulbis B, Fontaine J. Attenuation of cyclosporine A-induced vascular toxicity by ramipril. J Cardiovasc Pharmacol 1994;24;17-21.
18. Lamb FS, Webb RC. Cyclosporin augments reactivity of isolated blood vessels. Life Sci 1987;40:2571-2578.
19. Meyer-Lehnert HM, Schrier RW. Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 1989;13:352-360.
20. Pfeilschifter J, Rüegg UT. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J 1987;24:883-887.
21. 2+. Circ Res 1994;74:477-484.
22. Sudhir K, MacGregor JS, DeMarco T, et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 1994;90:3018-3023.
23. Rego A, Vargas R, Wroblewska B, Foegh ML, Ramwell PW. Attenuation of vascular relaxation and cyclic GMP responses by cyclosporin A. J Pharmacol Exp Ther 1990;252: 165-170.